Tiansheng Pharmaceutical Group Co., Ltd. (SHE:002872)

China · Delayed Price · Currency is CNY

5.05

0.00 (0.00%)

Aug 4, 2026, 3:04 PM CST

7.68% (1Y)

Market Cap	1.61B +7.7%
Revenue (ttm)	530.52M -1.3%
Net Income	-52.79M
EPS	-0.17
Shares Out	318.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,700,800
Open	5.07
Previous Close	5.05
Day's Range	5.05 - 5.13
52-Week Range	4.32 - 5.81
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 25, 2026

About SHE:002872

Tiansheng Pharmaceutical Group Co., Ltd. engages in pharmaceutical manufacturing and circulation activities. The company offers pediatric cough granules, erythromycin enteric-coated capsules, yinshen tongluo capsules, yanshen jianwei capsules, and sodium chloride injection products. It provides products in various categories, including respiratory, cardiovascular and cerebrovascular, urinary system, pediatrics, digestive, gynecological, orthopedic, cardiology, diabetes, anesthetic, oncology, hepatobiliary, hematological, surgical, and others. I... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2001

Employees 1,273

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 002872

Full Company Profile

Financial Performance

In 2025, SHE:002872's revenue was 514.09 million, a decrease of -9.76% compared to the previous year's 569.71 million. Losses were -55.42 million, -36.59% less than in 2024.

Financial Statements